Latest 8-K filings

IDEAYA Biosciences announced positive Q2 2026 financial results, highlighted by a registrational trial success for darovasertib and a strengthened cash position extending runway to 2030.

Prologis, Inc. announced a recommended offer to acquire SEGRO plc for approximately £14.0 billion, aiming to enhance its global logistics real estate platform.

Gartner reported strong second quarter 2026 results, exceeding expectations for Adjusted EPS and Adjusted EBITDA, and increased full-year guidance.

Lisata Therapeutics announced a 72% workforce reduction, estimated $1.2 million in costs, and initiated legal action against Kuva Labs for breach of a merger agreement.

FB Bancorp, Inc. announced the retirement of Dr. Stephen W. Hales from its Board of Directors and appointed Mark Romig as Chair of the Nominating/Governance Committee.

Galera Therapeutics, Inc. has completed its merger with Obsidian Therapeutics, Inc., becoming a wholly owned subsidiary and ceasing its OTCQB listing.

Vivos Therapeutics, Inc. announces the departure of its CFO, Bradford Amman, and the appointment of Roman Franklin as interim CFO through a services agreement with The CFO Portal, LLC.

8x8, Inc. announced the results of its 2026 Annual Meeting of Stockholders, with overwhelming support for director elections, executive compensation, and an amendment to its equity incentive plan.

Lantern Pharma establishes Open-Medicine AI as a separate entity to commercialize its multi-agent AI co-scientist platform, expanding beyond oncology.

Paymentus Holdings, Inc. announced robust second quarter 2026 financial results, featuring a 28.8% year-over-year revenue increase and record adjusted EBITDA margin.

Intelligent Bio Solutions Inc. announced the completion of its Interference Study for the Intelligent Fingerprinting Drug Screening System, a crucial step towards FDA 510(k) submission for U.S. market clearance.

Teads Holding Co. has filed a lawsuit against Google LLC and Alphabet Inc. in the U.S. District Court for the Southern District of New York, seeking financial damages and other remedies.

Banner Corporation's Board of Directors has approved a program to repurchase up to 1.7 million shares of its common stock, representing approximately 5% of outstanding shares.

Capstone Holding Corp. has amended its senior secured convertible note, extending the maturity date of a previously issued note by one month.

Intelligent Bio Solutions Inc. announced an updated total of 3,018,188 outstanding common shares as of July 31, 2026, resulting from recent stock sales, warrant exercises, and advisory agreements.

Ainos, Inc. announced its second quarter 2026 financial results, revealing a substantial decrease in revenue and an increased net loss, while highlighting continued progress in its AI Nose technology deployments.

Mobia Medical, Inc. has expanded its Board of Directors by appointing Dr. Myriam J. Curet, a seasoned executive with extensive experience in medical technology and surgery.

Arbor Realty Trust's August 2026 investor presentation showcases a robust multifamily lending platform, strong capital structure, and a strategic approach to managing non-performing assets.

BioLife Solutions announces its merger with Repligen Corporation, aiming to accelerate growth and enhance bioprocessing capabilities.

Cycurion, Inc. announced a warrant inducement transaction to exercise existing warrants, raising approximately $4.5 million in gross proceeds and issuing new warrants.

Sharing Economy International Inc. has completed a share exchange agreement to acquire Light Across, Inc., an electric vehicle engineering, design, and manufacturing company, marking a significant shift from its previous shell company status.

Moleculin Biotech, Inc. announced the closing of a public offering, raising approximately $9.3 million to fund its clinical development programs.

Paycom Software, Inc. announced its Board of Directors has declared a regular quarterly cash dividend of $0.375 per share.

Obsidian Therapeutics, Inc. announced the completion of its merger with Galera Therapeutics, Inc. and a $350 million private placement, bolstering its cash position to fund operations into late 2028.

Fabric.AI and Kopin Corporation have published a white paper detailing MicroLED optical interconnects as a solution for next-generation AI infrastructure bottlenecks.

LogicMark, Inc. has entered into a definitive agreement to be acquired by Langham Project, LLC in a merger transaction that will result in the company becoming privately held.

Commercial Vehicle Group Inc. announced second quarter 2026 results, showcasing a 13.5% revenue increase to $195.2 million and raising full-year guidance, despite a net loss.

Stoke Therapeutics has filed a prospectus supplement to offer up to $200 million in common stock through an at-the-market offering.

Granite Point Mortgage Trust Inc. has amended its Master Repurchase Agreement with JPMorgan Chase Bank, extending the facility's maturity and increasing its capacity.

Camden Property Trust announced the retirement of Executive Vice Chairman D. Keith Oden, who will continue to serve on the Board of Trust Managers.